Which drugs are most likely to be approved in Lentivirus Infections?

Lentivirus Infections disease is an indication for drug development with over 520 pipeline drugs currently active according to GlobalData.

Novo to buy mid-stage heart failure biotech Cardior for up to $1.1B

Novo Nordisk plans to acquire German biotech Cardior Pharmaceuticals, a Phase 2 RNA startup, for up to $1.1 billion to boost its presence in cardiovascular disease, the

March 26, 2024

Optimi Health to Supply MDMA for Psychedelic Research at Tel Aviv University | Psychedelic Invest

VANCOUVER, British Columbia, March 26, 2024 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Health Canada licensed psychedelics pharmaceutical manufacturer, specializing

March 26, 2024

Patent Analysis: Lykos Suffers Blow from USPTO As All Patent Claims Stand Finally Rejected – Psychedelic Alpha

On September 6, 2024, the results of the first substantive examination of Lykos’ U.S. application (US 18/611,564) posted. The Non-Final Office Action (NFOA) introduced a

January 16, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.